Preprocedural Prediction of Underlying Atherosclerotic Lesions in Cerebral Large-Vessel Occlusions: Clinical Backgrounds, Radiological Findings, and Treatment Outcomes.


Journal

Journal of atherosclerosis and thrombosis
ISSN: 1880-3873
Titre abrégé: J Atheroscler Thromb
Pays: Japan
ID NLM: 9506298

Informations de publication

Date de publication:
01 Nov 2022
Historique:
pubmed: 24 12 2021
medline: 8 11 2022
entrez: 23 12 2021
Statut: ppublish

Résumé

Mechanical thrombectomy using a standard device has been effective for acute cerebral large-vessel occlusions, particularly those due to cardiogenic embolism. However, evidence for those with underlying atherosclerotic lesions is lacking. In this study, we evaluated the predictive factors, treatment details, and outcomes of acute cerebral large-vessel occlusions with underlying atherosclerotic lesions in patients who underwent mechanical thrombectomy. We retrospectively analyzed consecutive patients with acute large-vessel occlusions who underwent mechanical thrombectomy at our institution between August 2014 and May 2021. Predictive factors of underlying atherosclerotic lesions were evaluated using univariate and multivariate analyses. In addition, treatment details and outcomes were evaluated and compared with those of other etiologies. Among 322 included patients, 202 (62.7%) were males and 65 (20.2%) had underlying atherosclerotic lesions. Multivariate analysis identified dyslipidemia, lack of arterial fibrillation documented on admission, smoking, internal carotid artery lesions, and stenosis ≥ 25% in non-occluded large vessels as predictive factors of underlying atherosclerotic lesions. Regarding treatment for underlying atherosclerotic lesions, the need for percutaneous transluminal angioplasty, stent placement, medical therapy, and longer procedure time were observed, while successful reperfusion rates, favorable outcomes, and mortality rates showed no significant differences with those of other etiologies. Coexisting diseases and radiological findings were useful for predicting underlying atherosclerotic lesions. Further understanding these characteristics may lead to the early detection of underlying atherosclerotic lesions, optimal treatment strategies, and better outcomes.

Identifiants

pubmed: 34937834
doi: 10.5551/jat.63135
pmc: PMC9623080
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1613-1624

Références

Stroke. 2003 Aug;34(8):e109-37
pubmed: 12869717
Neurosurgery. 2015 Jun;76(6):680-6; discussion 686
pubmed: 25988927
Stroke. 2019 Jun;50(6):1460-1466
pubmed: 31084327
J Neurointerv Surg. 2017 Oct;9(10):948-951
pubmed: 27502403
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
JAMA. 2017 Aug 1;318(5):443-452
pubmed: 28763550
Stroke. 2011 Dec;42(12):3454-9
pubmed: 21960577
Circ J. 2007 Jul;71(7):995-1003
pubmed: 17587702
J Atheroscler Thromb. 2018 Sep 1;25(9):846-984
pubmed: 30135334
J Neurointerv Surg. 2017 Dec;9(12):1154-1159
pubmed: 27986848
J Neurointerv Surg. 2018 Aug;10(8):746-750
pubmed: 29203731
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
Neurology. 2016 Oct 11;87(15):1542-1550
pubmed: 27629085
J Stroke. 2017 May;19(2):143-151
pubmed: 28592778
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Interv Neuroradiol. 2019 Jun;25(3):254-260
pubmed: 30514143
N Engl J Med. 2018 Feb 22;378(8):708-718
pubmed: 29364767
AJNR Am J Neuroradiol. 2004 Jan;25(1):88-91
pubmed: 14729535
Stroke. 1994 Nov;25(11):2220-6
pubmed: 7974549
Clin Neuroradiol. 2018 Sep;28(3):327-338
pubmed: 28194477
Int J Stroke. 2020 Feb;15(2):122-131
pubmed: 31537182
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Interv Neuroradiol. 2016 Jun;22(3):325-32
pubmed: 26908591
Front Neurol. 2019 May 08;10:499
pubmed: 31133981
BMC Neurol. 2020 Jul 18;20(1):283
pubmed: 32682406
N Engl J Med. 2018 Jan 4;378(1):11-21
pubmed: 29129157
Stroke. 1988 May;19(5):604-7
pubmed: 3363593
Stroke. 2018 Nov;49(11):2699-2705
pubmed: 30355204
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
J Stroke Cerebrovasc Dis. 2021 Feb;30(2):105478
pubmed: 33248344
Acad Radiol. 2009 Mar;16(3):305-12
pubmed: 19201359
J Neurointerv Surg. 2015 Feb;7(2):90-4
pubmed: 24463439
Stroke. 2017 Nov;48(11):3145-3148
pubmed: 28974628
Cerebrovasc Dis. 2010;29(1):82-6
pubmed: 19907168

Auteurs

Tomoyoshi Kuribara (T)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Hiroki Sato (H)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Satoshi Iihoshi (S)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Eisuke Tsukagoshi (E)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Akio Teranishi (A)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Yu Kinoshita (Y)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Shin Sugasawa (S)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Shinya Kohyama (S)

Department of Endovascular Neurosurgery, Saitama Medical University International Medical Center.

Shinichi Takahashi (S)

Department of Neurology and Cerebrovascular Medicine, Saitama Medical University International Medical Center.

Hiroki Kurita (H)

Department of Cerebrovascular Surgery, Saitama Medical University International Medical Center.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH